Search Results
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
Dr. Louis Weiner Discusses the T-DM1 EMILIA Trial for HER2-Positive Breast Cancer
Dr. Esteva Discusses T-DM1 in HER2-Positive Breast Cancer
Dr. Louis M. Weiner on Immunoconjugates
Dr. Tripathy Discusses Impact of T-DM1 in HER2+ Breast Cancer
Dr. Jhaveri Discusses the Utility of T-DM1 in the Neoadjuvant Setting
Dr. Julie Gralow Discusses T-DM1-Induced Thrombocytopenia
Upfront T-DM1 in HER2-Positive Breast Cancer
Dr. Louis Weiner defines immunotherapy
Dr. Mark Pegram Discusses Earlier Treatment With T-DM1
How Breast Cancer Treatment Kadcyla (T-DM1) Works
Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1